Company: NDRA
Filing Date: 2025-10-17
Form Type: PRE 14A
Source: 0001654954-25-011931
Chunk: 4

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-17
Form: PRE 14A
Chunk 4
---
 and the form of proxy are being made available, and the Notice of Internet Availability of Proxy Materials (the “Notice”) is being mailed, to stockholders on or about October 28, 2025.

<div align='center'>GENERAL INFORMATION</div>

Why am I receiving these materials?

You have received these proxy materials because the Board of Directors of the Company (the “Board”) is soliciting your proxy to vote your shares at the 2025 Annual Meeting. This proxy statement includes information that we are required to provide to you under Securities and Exchange Commission (“SEC”) rules and is designed to assist you in voting your shares.

Pursuant to the “notice and access” rules adopted by the SEC, we have elected to provide stockholders access to our proxy materials over the internet. Accordingly, we sent the Notice to all of our stockholders of record at the close of business on October 16, 2025, the record date fixed by the Board for determining the stockholders entitled to notice of and to vote at the 2025 Annual Meeting (the “record date”). The Notice includes instructions on how to access our proxy materials over the internet and how to request a printed copy of these materials. In addition, by following the instructions in the Notice, stockholders may request to receive proxy materials in printed form by mail or electronically by email on an ongoing basis.

What is a proxy?

The Board is asking for your proxy. This means that you authorize persons selected by us to vote your shares at the 2025 Annual Meeting in the way that you instruct. We have designated two of our executive officers to serve as proxy holders for the 2025 Annual Meeting. All shares represented by valid proxies received before the vote at the 2025 Annual Meeting will be voted in accordance with the stockholder’s specific voting instructions.

What is included in these materials?

These materials include:

| 6 |

What items will be voted on at the 2025 Annual Meeting?

There are six proposals scheduled to be voted on at the 2025 Annual Meeting:

| · 
 · 
 · | the election of the four nominees named in this proxy statement to the Board to serve one-year terms expiring at the 2026 annual meeting of stockholders (each to serve until their successors are duly elected and qualified or until their earlier death, resignation, or removal); 
 the approval, on a non-binding, advisory basis, of executive compensation (“Say-on-Pay”);                                                                                                                                                                                             
 the ratification of the Audit Committee’s appointment of